Delivery Order SPM20002D3002-A027

This federal contract award, with a value of $1,300.25, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4565082550 units of Oseltamivir Phosphate 75 mg Capsules, a medication used to treat influenza, with a completion date of July 9, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a larger...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10 tablets, with a ceiling value of $59,932.80 and an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Oseltamivir, an antiviral medication...

<p>The Defense Logistics Agency issued a $1,758.45 delivery order to Amerisourcebergen Drug Corp on February 11, 2026, for Oseltamivir Phosphate 75 mg capsules (100-count packaging).</p> <p>Place of performance is Conshohocken, PA. The order has a firm fixed price structure and an ultimate completion date of February 12, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a $5,111.78 delivery order to Amerisourcebergen Drug Corp on February 9, 2026, for Oseltamivir Phosphate 75 mg capsules (unit dose, 10-count).</p> <p>Place of performance is Conshohocken, PA. The order ceiling value is $5,111.78 with an ultimate completion date of February 10, 2026. Pricing is firm fixed price. No set-aside was used.</p>

The Defense Logistics Agency awarded a $9,305.18 delivery order to Amerisourcebergen Drug Corporation for the provision of 4562162924 oseltamivir phosphate 75 mg capsules in quantities of 10 capsules per package. The place of performance for this firm fixed price contract is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The contract period of performance spans from September 13, 2023 through September 14, 2023 to support the Department of Defense's stockpiling and...

<p>The Defense Logistics Agency issued a $8,412.16 delivery order to Amerisourcebergen Drug Corp on February 11, 2026, for oseltamivir phosphate 75 mg capsules (unit dose, 10s). Ultimate completion date is February 12, 2026. Place of performance is Conshohocken, PA 19428. Pricing is firm fixed price with no set-aside used.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 9, 2026, for Oseltamivir Phosphate 75 mg capsules with a ceiling value of $1,369.06.</p> <p>Place of performance is Conshohocken, PA. The order carries an ultimate completion date of February 10, 2026, and is priced on a firm fixed-price basis. No set-aside was applied.</p>

<p>The Defense Logistics Agency issued a $1,613.63 delivery order to Amerisourcebergen Drug Corp on April 29, 2026, for oseltamivir phosphate 75 mg capsules (100-count).</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of April 30, 2026. No set-aside was used.</p>

The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,747.48 for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 count. This is a firm fixed-price delivery order with no set-aside designation, awarded on December 19, 2025, with an ultimate completion date of December 22, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Oseltamivir is an antiviral medication commonly used for influenza...

<p>The Defense Logistics Agency issued a $1,879.48 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for oseltamivir phosphate 75 mg capsules.</p> <p>Place of performance is Conshohocken, PA. The order closes February 6, 2026. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc.</p>